Yeganeh Reuven, a director at BiomX Inc. ($PHGE), made two open market sales of common shares over the last 365 days, totaling $3.35 million. The most recent sale occurred on March 13, 2026. These sales rank 2,519th among 11,678 individual insiders in our database, where the average sale amount is $8.59 million across about 6.4 transactions per insider. Reuven recorded no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | BiomX Inc. | $PHGE | Yeganeh Reuven | Director | C | Common Stock, $0.0001 par value per share | 450000 | $2.00 | 450,000.0000 | 1,631,037 | 9999.99% | 27.59% |
| March 16, 2026 | BiomX Inc. | $PHGE | Yeganeh Reuven | Director | S | Common Stock, $0.0001 par value per share | 450000 | $5.00 | 0.0000 | 1,631,037 | 100.00% | 27.59% |
| March 17, 2026 | BiomX Inc. | $PHGE | Yeganeh Reuven | Director | C | Common Stock, $0.0001 par value per share | 530000 | $2.00 | 530,000.0000 | 1,631,037 | 9999.99% | 32.50% |
| March 17, 2026 | BiomX Inc. | $PHGE | Yeganeh Reuven | Director | S | Common Stock, $0.0001 par value per share | 530000 | $5.00 | 0.0000 | 1,631,037 | 100.00% | 32.50% |
| March 16, 2026 | BiomX Inc. | $PHGE | Yeganeh Reuven | Director | C | Series Y Convertible Preferred Stock | 900 | $0.00 | 1,060.0000 | 1,631,037 | 45.92% | 0.06% |
| March 17, 2026 | BiomX Inc. | $PHGE | Yeganeh Reuven | Director | C | Series Y Convertible Preferred Stock | 1060 | $0.00 | 0.0000 | 1,631,037 | 100.00% | 0.06% |
| March 16, 2026 | BiomX Inc. | $PHGE | Yeganeh Reuven | Director | S | Common Stock Purchase Warrants | 1300000 | $5.00 | 2,000,000.0000 | 1,631,037 | 39.39% | 79.70% |
| March 16, 2026 | BiomX Inc. | $PHGE | Yeganeh Reuven | Director | S | Common Stock Purchase Warrants | 2000000 | $5.24 | 1,700,000.0000 | 1,631,037 | 54.05% | 100.00% |
| March 16, 2026 | BiomX Inc. | $PHGE | Yeganeh Reuven | Director | S | Common Stock Purchase Warrants | 1700000 | $4.76 | 0.0000 | 1,631,037 | 100.00% | 100.00% |
| March 11, 2026 | BiomX Inc. | $PHGE | Yeganeh Reuven | Director | C | Common Stock, $0.0001 par value per share | 300000 | $2.00 | 30,000.0000 | 1,631,037 | 0.00% | 18.39% |
| March 12, 2026 | BiomX Inc. | $PHGE | Yeganeh Reuven | Director | S | Common Stock, $0.0001 par value per share | 300000 | $5.00 | 0.0000 | 1,631,037 | 100.00% | 18.39% |
| March 13, 2026 | BiomX Inc. | $PHGE | Yeganeh Reuven | Director | C | Common Stock, $0.0001 par value per share | 370000 | $2.00 | 370,000.0000 | 1,631,037 | 9999.99% | 22.69% |
| March 13, 2026 | BiomX Inc. | $PHGE | Yeganeh Reuven | Director | S | Common Stock, $0.0001 par value per share | 370000 | $5.00 | 0.0000 | 1,631,037 | 100.00% | 22.69% |
| March 12, 2026 | BiomX Inc. | $PHGE | Yeganeh Reuven | Director | C | Series Y Convertible Preferred Stock | 600 | $0.00 | 2,700.0000 | 1,631,037 | 18.18% | 0.04% |
| March 13, 2026 | BiomX Inc. | $PHGE | Yeganeh Reuven | Director | C | Series Y Convertible Preferred Stock | 740 | $0.00 | 1,960.0000 | 1,631,037 | 27.41% | 0.05% |
| Nov. 13, 2025 | T3 Defense Inc. | $DFNS | Yeganeh Reuven | Director | A | Common Stock, $0.0001 par value per share | 10000 | $0.00 | 20,000.0000 | 8,124,786 | 100.00% | 0.12% |
| Dec. 16, 2024 | T3 Defense Inc. | $DFNS | Yeganeh Reuven | Chief Executive Officer | A | Common Stock, $0.0001 par value per share | 10000 | $1.39 | 10,000.0000 | 2,043,928 | 9999.99% | 0.49% |